Health Trials

Asian Myeloproliferative Neoplasm (MPN) Registry

ConditionsMyeloproliferative NeoplasmPolycythemia VeraEssential ThrombocythemiaPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic StagePrimary Myelofibrosis, Fibrotic Stage
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe University of Hong Kong

About this trial

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Eligibility criteria

Qualifiers

Age ≥ 18 years old at the time of diagnosis of MPN.

Polycythaemia vera

Essential thrombocythemia

Primary myelofibrosis, pre-fibrotic/early stage

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

The University of Hong Kong

Lead sponsor

Novartis

Collaborator

Source ClinicalTrials.gov